Osteoprotegerin is a Strong Biomarker of Vascular Calcification in Maintenance Hemodialysis Patients: a Cross-sectional Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20210316014

Enrollment

Registered

2021-03-16

Start date

2020-08-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Maintenance hemodialysis patients with vascular calcification Maintenance hemodialysis patients with vascular calcification

Interventions

clinical stable Maintenance hemodialysis patients, age above 18 year

Diagnostic

Maintenance hemodialysis patients

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age > 18 years maintenance hemodialysis Informed consent Informed consent

Exclusion criteria

Exclusion criteria: Pregnancy Recent percutaneous coronary intervention Presence of coronary artery bypass grafting

Design outcomes

Primary

Measure	Time frame
Osteoprotegerin level and Coronary artery calcification score at the begin of the study Osteoprotegerin level measurement by ELISA, Coronary artery calcification score by CT scan	—

Secondary

Measure	Time frame
factor for predict coronary calcification score at the beginning of study blood test	—

Countries

Thailand

Contacts

Public ContactMalinporn Jampong

Department of Medicine, Phramongkutklao Hospital and College of Medicine

malinpornj@gmail.com0815830858

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026